期刊文献+

纳米羟基磷灰石介导靶向hTERT的RNA干扰可有效抑制人肺癌A549细胞增殖

Hydroxyapatite nanoparticles mediated human teiomerase reverse transcriptase RNA interference of A549 human lung cancer cells in vitro
原文传递
导出
摘要 目的探讨纳米羟基磷灰石(nHAP)介导靶向端粒酶逆转录酶(hTERT)的RNA干扰对人肺癌A549细胞的影响。方法采用均相沉淀法制备nHAP。分为nHAP—PLL组、脂质体组、nHAP组及对照组,分别配制转染复合物并转染人肺癌A549细胞。MTT法测定细胞生长活力;Western Blot检测hTERT蛋白表达,流式细胞仪检测细胞凋亡率。结果nHAP-PLL组、脂质体组与nHAP组的A549细胞增殖受到抑制,较对照组差异有统计学意义(P〈0.05);nHAP—PLL组抑制细胞增殖较脂质体组及nHAP组明显,差异均有统计学意义(P〈0.05)。各组的hTERT蛋白表达的变化趋势与人肺癌A549细胞的增殖情况一致。流式细胞仪检测nHAP—PLL组、脂质体组及nHAP组均有不同程度的细胞凋亡,凋亡率与对照组差异有统计学意义,P〈0.05。结论nHAP本身能诱导人肺癌A549细胞凋亡,经PLL修饰后能有效地结合保护DNA并介导人肺癌A549细胞的基因转染,介导靶向hTERT的RNA干扰可有效抑制人肺癌A549细胞增殖。 Objective To investigate the effect of hydroxyapatite nanoparticles (nHAP) mediated human telomerase reverse transcriptase (hTERT) RNA interference of A549 human lung cancer cells in vitro. Methods The nHAP were synthesized by the homogeneous precipitation method. The structure of the nanoparticles was observed under transmission electron microscope. The nHAP were prepared using uhrasonication and Na2CO3 and modified with poly-L-lysine (PLL) at pH 7.4. The transfection of pGenesil-hTERT into A549 was divided into four groups as follows : nHAP-PLL group mediated by hydroxyapatite nanoparticles modified with poly-L-lysine (nHAP-PLL), liposome group mediated by Lipofectamine, nHAP group mediated by hydroxyapatite nanoparticles and control group. The growth ability of cells was assayed with methyl thiasolyl tetrazolium method. The expression level of hTERT protein was examined by Western blotting. Flow cytometry was used to detect the apoptosis ratio of A549 cells line. Results Under transmission electron microscope, the synthesized product presented needle-like and well dispersed particles with evenly distributed sizes of (15 -20) nm × (60-80) nm. The proliferation of A549 cells of nHAP-PLL group, liposome group and nHAP group were obviously inhibited as compared with the control group ( P 〈 0.05 ). The inhibition rate of nHAP-PLL group was more than the other groups. There was a significant difference inhibition rate between the nHAP-PLL group compared with the liposome group and nHAP group ( P 〈 0.05 ). The level of hTERT protein had a similar varietal tendency with the result of proliferation of each group. Flow cytometry showed the apoptosis ratio of nHAP-PLL group, liposome group, nHAP group and control group was (28.1 ±1.4) %, ( 19.2 ±1.3 ) %, ( 10.9 ±1.2) % and (0.3 ±0.2 ) %, respectively. There was a significant difference in apoptosis ratio between the nHAP-PLL group, liposome group and nHAP group compared with control group(P 〈 0.05 ). Conclu
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2010年第1期41-44,共4页 Chinese Journal of Thoracic and Cardiovascular Surgery
关键词 羟基磷灰石类 端粒 RNA指导的DNA聚合酶 肺肿瘤 A549细胞 纳米颗粒 Hydroxyapatites Telomere RNA-directed DNA polymerase Lung neoplasms A549 Cell line Nanoparticles
  • 相关文献

参考文献3

二级参考文献43

  • 1Yun-Lin Wu~1 Bo Sun~1 Xue-Jun Zhang~2 Sheng-Nian Wang~2 Heng-Yi He~2 Min-Min Qiao~1 Jie Zhong~1 Jia-Yu Xu~1 1 Department of Gastroenterology,Ruijin Hospital,Shanghai Second Medical University,Shanghai 200025,China2 Institude of Biochemistry and Cell Biology,Shanghai Institues for Biological Sciences,Chinese Academy of Sciences.Shanghai 200025,China.Growth inhibition and apoptosis induction Sulindac on Human gastric cancer cells[J].World Journal of Gastroenterology,2001,7(6):796-800. 被引量:64
  • 2He SW,Shen KQ,He YJ,Xie B,Zhao YM.Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma[J].World Journal of Gastroenterology,1999,5(5):408-416. 被引量:20
  • 3LUO D, SALTZMAN W M. Synthetic DNA delivery systems [J]. Nat Biotechnol, 2000, 18(1): 33-37. 被引量:1
  • 4ANDERSON W F. Human gene therapy [J].Nature, 1998, 392(6679 Suppl): 25 -30. 被引量:1
  • 5KRISANAPIBOON A, BURANAPANITKIT B, OUNGBHO K. Bioeompatability of hydroxyapatite composite as a local drug delivery system [J].J Orthop Surg, 2006, 14 (3): 315- 318. 被引量:1
  • 6XU Z P, WALKER T L, LIU K L, et al. Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA [J].Int J Nanomedicine, 2007, 2(2):163- 174. 被引量:1
  • 7KNEUER C, SAMETI M, HALTNER E G, et al. Silica nanoparticles modified with aminosilanes as carriers for plasmidDNA [J].Int J Pharm, 2000, 196(2):257-261. 被引量:1
  • 8MINIGO G, SCHOLZEN A, TANG C K, et al. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy [J]. Vaccine, 2007, 25 (7): 1316-1327. 被引量:1
  • 9LIU Q, DE WIJN J R, DE GROOT K, et al. Surface modification of nano apatite by grafting organic polymer [J]. Biomaterials, 1998, 19(11/12): 1067-1072. 被引量:1
  • 10OUPICKY D, KONAK C, ULBRICH K, et al. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers[J].J Control Release, 2000, 65(1/2) : 149-171. 被引量:1

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部